| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/08/2007 | WO2007016379A2 Method for improving cell permeability to foreign particles |
| 02/08/2007 | WO2007016367A2 Neoplastic disease-related methods, kits, systems and databases |
| 02/08/2007 | WO2007016331A2 Classification and diagnosis of the molecular basis of cholestasis |
| 02/08/2007 | WO2007016291A2 Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| 02/08/2007 | WO2007016275A2 Methods and compositions for detecting bk virus |
| 02/08/2007 | WO2007016269A2 Detection of polyphosphate using fluorescently labeled polyphosphate acceptor substrates |
| 02/08/2007 | WO2007016267A2 System for water removal and solvent evaporation |
| 02/08/2007 | WO2007016239A2 Herpes simplex virus mutant and uses therefore |
| 02/08/2007 | WO2007016210A2 Methylation markers for prognosis and treatment of cancers |
| 02/08/2007 | WO2007016189A2 Glucose transport-related genes, polypeptides, and methods of use thereof |
| 02/08/2007 | WO2007016160A2 Svct2 transporters expressed in blood brain barrier cells |
| 02/08/2007 | WO2007015993A1 Methylation specific primer extension assay for the detection of genomic imprinting disorders |
| 02/08/2007 | WO2007015947A2 Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies |
| 02/08/2007 | WO2007015945A2 Development of novel germplasm using segregates from transgenic crosses |
| 02/08/2007 | WO2007015926A2 Multiparameter flow cytometric cytometric cytotoxicity systems, methods, compositions and kits for evaluating the susceptibility of cancer |
| 02/08/2007 | WO2007015878A2 Method for measuring cytopathic effect in cells using electric cell-substrate impedance sensing |
| 02/08/2007 | WO2007015578A1 Method for assay on the effect of vascularization inhibitor |
| 02/08/2007 | WO2007015569A1 Method for prediction of the efficacy of vascularization inhibitor |
| 02/08/2007 | WO2007015557A1 Novel artificial base pair and use thereof |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007015459A1 Gene set for use in prediction of occurrence of lymph node metastasis of colorectal cancer |
| 02/08/2007 | WO2007014992A2 Antibodies directed against an ldl receptor |
| 02/08/2007 | WO2007014951A2 Methods for the screening of antibacterial substances |
| 02/08/2007 | WO2007014500A1 Differential expression gene profiles and applications in molecular staging of human gastric cancer |
| 02/08/2007 | WO2007014468A1 Development of pcr primers and primer mixtures for amplification of cnp60 target sequences |
| 02/08/2007 | WO2007014467A1 DlAGNOSIS AND TREATMENT OF MOOD DISORDERS |
| 02/08/2007 | WO2007014463A1 Nalp7-based diagnosis of female reproductive conditions |
| 02/08/2007 | WO2007014460A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2006135611A3 Method of hydrogen production in a bioreactor having a circulation system |
| 02/08/2007 | WO2006131599A3 Method of profiling a cell population |
| 02/08/2007 | WO2006124904A3 Cancer treatment by combined inhibition of telomerase and hsp90 activities |
| 02/08/2007 | WO2006113422A3 Human sweet and umami taste receptor variants |
| 02/08/2007 | WO2006094238A3 Compositions for use in identification of adventitious viruses |
| 02/08/2007 | WO2006088576A3 Polypeptide formulations and methods for making, using and characterizing them |
| 02/08/2007 | WO2006078289A3 Bio-barcode based detection of target analytes |
| 02/08/2007 | WO2006071895A3 Nanoelectronic devices for dna detection, and recognition of polynucleotide sequences |
| 02/08/2007 | WO2006067506A3 Hiv resistance genes |
| 02/08/2007 | WO2006067487A3 Use of cytochrome p450 reductase as insecticidal target |
| 02/08/2007 | WO2006066369A3 Method and kit for the detection of a large number of genes related to antibiotic resistance in microorganisms |
| 02/08/2007 | WO2006065938A3 Cancer-specific spanx-n markers |
| 02/08/2007 | WO2006063042A3 Selecting patients for therapy with a her inhibitor |
| 02/08/2007 | WO2006060484A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 02/08/2007 | WO2006053322A3 Compositions and methods for inferring an adverse effect in response to a drug treatment |
| 02/08/2007 | WO2006048886A3 Laboratory devices, methods and systems employing acoustic ejection devices |
| 02/08/2007 | WO2006042192A3 Relevance of achieved levels of markers of systemic inflammation following treatment |
| 02/08/2007 | WO2006036246A3 Simplified methods for isolating nucleic acids from cellular materials |
| 02/08/2007 | WO2005110490A8 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/08/2007 | WO2005110468A3 Treatment of insulin resistance/metabolic syndrome to alleviate the risks of dementia |
| 02/08/2007 | WO2005084257A3 Composite thin-film glucose sensor |
| 02/08/2007 | WO2005044987A3 Tocopherol associated protein and uses thereof |
| 02/08/2007 | WO2005001049A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 02/08/2007 | WO2003068934A3 Chimeric molecules for cleavage in a treated host |
| 02/08/2007 | US20070033671 Polynucleotides and polypeptides in plants |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070033662 GLP-2 receptor gene promoter and uses thereof |
| 02/08/2007 | US20070032963 Method of ordering synthesis of primer used for gene amplification, program therefor and recording medium of the program |
| 02/08/2007 | US20070032718 Device and method for determining analyte levels |
| 02/08/2007 | US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 02/08/2007 | US20070032480 Treatment of ischemia-induced arrhythmias |
| 02/08/2007 | US20070032447 Production of reprogrammed cells with restored potential |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032442 Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells |
| 02/08/2007 | US20070032437 Iap binding compounds |
| 02/08/2007 | US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 02/08/2007 | US20070032414 Human secreted proteins |
| 02/08/2007 | US20070032413 Of given amino acid sequence; vectors, host cells, and recombination; diagnosing and treating diseases related to human secreted proteins |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031961 Biosensors and methods for their use |
| 02/08/2007 | US20070031941 Producing recombinant influenza virus in canine kidney cells; preparing attenuated vaccines for treatment of influenza |
| 02/08/2007 | US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
| 02/08/2007 | US20070031936 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031935 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031934 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/08/2007 | US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031923 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 02/08/2007 | US20070031917 System for Staining Fungi and Protozoa |
| 02/08/2007 | US20070031916 Apparatus and method for automated monitoring of airborne bacterial spores |
| 02/08/2007 | US20070031915 Blood and urine test |
| 02/08/2007 | US20070031914 Devices for analyte assays and methods of use |
| 02/08/2007 | US20070031913 Amino-acid biosensor, fischer-ratio biosensor and health information management system |
| 02/08/2007 | US20070031912 Method for analysis of protein interaction using fluorescent protein |
| 02/08/2007 | US20070031911 Isotopically-labeled proteome standards |
| 02/08/2007 | US20070031910 Method of stabilizing sample |
| 02/08/2007 | US20070031909 identifying a compound that modulates methylation of a protein phosphatase that affects a protein activity and determining that the protein activity is altered by modulating with the compound methylation of the protein phosphatase |
| 02/08/2007 | US20070031907 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031899 Using serine/threonine kinase Pim-1 polypeptide phosphorylation inhibition after exposure to modulator as indication of antitumor/cancer activity; treating pancreatic cancer |
| 02/08/2007 | US20070031898 Contacting a first portion of a peripheral blood sample that contains mononuclear cells with a fluorescence-labeled immunostimulant polysaccharide such as a beta-glucan or lentinan and measuring its fluorescent intensity to determine cell bonding; and comparing the intensity to that of a reference |
| 02/08/2007 | US20070031897 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP |
| 02/08/2007 | US20070031894 Novel nerve stem cell marker |
| 02/08/2007 | US20070031890 Methods and compositions for diagnosing and monitoring transplant rejection |
| 02/08/2007 | US20070031889 Method for rapidly detecting quinolone-resistant Salmonella ssp. and the probes and primers utilized therein |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031887 Aqueous-based pharmaceutical composition |
| 02/08/2007 | US20070031886 Detecting recessive diseases in inbred populations |
| 02/08/2007 | US20070031885 Amplifying the target in a reaction mixture of a reporter oligonucleotide; a nucleic acid polymerase; and a pair of oligonucleotide primers, where at least one has at least one non-natural base; analyzing mutations; quantitative analysis; one pot process; simplification; efficiency; high speed; kinetics |
| 02/08/2007 | US20070031884 Universal readout for target identification using biological microarrays |